The arrival of Retatrutide ZPHC, at a strength of 120mg, is generating considerable buzz within the weight loss community. This groundbreaking dual GIP and GLP-1 agonist medication appears to offer notable improvements in weight loss compared to existing therapies. Early patient data have demonst